Browse > Article
http://dx.doi.org/10.22246/jikm.2020.41.6.1052

A Pilot Study to Evaluate the Reliability of a Pattern Identification Tool for Benign Prostatic Hyperplasia and to Analyze Correlations between Pattern Identification Tools and International Prostate Symptom Score (IPSS) and Uroflowmetry  

Jeon, Cheon-hoo (Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University)
Gu, Ji-hyang (Dept. of Korean Medicine Rehabilitation, College of Korean Medicine, Dae-Jeon University)
Kang, Wee-chang (Dept. of Statistics, H-Liberal Arts College, Dae-Jeon University)
Jang, Eun-su (Dept. of Diagnosis, College of Korean Medicine, Dae-Jeon University)
Lee, Eun-jung (Dept. of Korean Medicine Rehabilitation, College of Korean Medicine, Dae-Jeon University)
Jung, In-chul (Dept. of Oriental Neuropsychiatry, College of Korean Medicine, Dae-Jeon University)
Cho, Chung-sik (Dept. of Internal Medicine, College of Korean Medicine, Dae-Jeon University)
Publication Information
The Journal of Internal Korean Medicine / v.41, no.6, 2020 , pp. 1052-1065 More about this Journal
Abstract
Objectives: To evaluate the reliability of a pattern identification tool for benign prostatic hyperplasia and to examine the relationship between pattern identification tool readings and IPSS and uroflowmetry. Methods: We analyzed 56 patients diagnosed with benign prostatic hyperplasia from December 27th, 2017 to December 26th, 2018 by two different Korean medical doctors and followed with a pattern identification tool and by IPSS and uroflowmetry. One week later, the patients were retested to analyze the reliability of the pattern identification tool, determined with the intraclass correlation coefficient (ICC) using the test-retest method. The correlation between IPSS and uroflowmetry was analyzed with the Pearson coefficient. Result: The reliability of the pattern identification tool for benign prostatic hyperplasia was evaluated as "poor agreement beyond chance" (ICC=0.349). The reliability of each pattern identification score was evaluated as "good" for Yang Deficiency of Kidney, Yin Deficiency of Kidney, Deficiency of Middle Qi, and Dampness-heat of Lower Energizer. The internal consistency was evaluated as "good" for Yang Deficiency of Kidney, Yin Deficiency of Kidney, and Dampness-heat of Lower Energizer, and as "excellent" for Deficiency of Middle Qi. The correlation between pattern identification and IPSS was evaluated as a "moderate positive correlation" for all pattern identifications. The average flow rate and maximum flow rate using uroflowmetry was evaluated with "moderate negative correlation" for Yang Deficiency of Kidney and Dampness-heat of Lower Energizer. Conclusion: The reliability of a pattern identification tool for benign prostatic hyperplasia was evaluated as "poor agreement beyond chance." Further research is needed.
Keywords
benign prostatic hyperplasia; pattern identification tool; reliability; IPSS; uroflowmetry;
Citations & Related Records
Times Cited By KSCI : 14  (Citation Analysis)
연도 인용수 순위
1 Bae GE, Lee SH, Hong JW, Lee I, Kim SY, Choi JY, et al. Moxibustion for benign prostatic hyperplasia: a systematic review and metaanalysis. J Intern Korean Med 2018;39(3):372-88.   DOI
2 Park SH, Han SR, Kang JS, Ahn YM, Ahn SY, Lee HJ, et al. A retrospective and cross-sectional study on symptom improvements in benign prostatic hyperplasia patients treated with electroacupuncture and bee venom acupuncture. J Intern Korean Med 2010;31(3):437-47.
3 Zhang W, Ma L, Bauer BA, Liu Z, Lu Y. Acupuncture for benign prostatic hyperplasia: A systematic review and meta-analysis. PLoS One 2017;12(4):e0174586.   DOI
4 Ma CH, Lin WL, Lui SL, Cai XY, Wong VT, Ziea E, et al. Efficacy and safety of Chinese herbal medicine for benign prostatic hyperplasia: systematic review of randomized controlled trials. Asian J Androl 2013;15(4):471-82.   DOI
5 Wang Y, Liu BY, Yu JN, Wu JN, Wang J, Liu ZS. Electroacupuncture for moderate and severe benign prostatic hyperplasia: a randomized controlled trial. PLoS One 2013;8(4):e59449.   DOI
6 Chen WF, Huang XQ, Peng A, Chen TT, Yang RZ, Huang YP, et al. Kangquan Recipe Regulates the Expression of BAMBI Protein via the TGF-β/Smad Signaling Pathway to Inhibit Benign Prostatic Hyperplasia in Rats. Evidence-Based Complement Altern Med 2019;2019:6281819.
7 Cai H, Zhang G, Yan Z, Shang X. The Effect of Xialiqi capsule on testosterone-induced benign prostatic hyperplasia in rats. Evidence-Based Complement Altern Med 2018;2018.
8 Smith F. Research Methods in Pharmacy Practice. London: Pharmaceutical Press; 2002, p. 43-84.
9 Hwang MN, Ha NY, Ko SJ, Park JW, Kim JS. Development of a Food Retention Questionnaire for Functional Dyspepsia and the Analysis of Its Reliability and Validity. J Intern Korean Med 2019;40(3):390-408.   DOI
10 Berle CA, Cobbin D, Smith N, Zaslawski C. A novel approach to evaluate traditional Chinese medicine treatment outcomes using pattern identification. J Altern Complement Med 2010;16(4):357-67.   DOI
11 Oh SJ, Jang ES, Oh YS, Kang WC, Lee EJ, Jung IC. A Pilot Study to Evaluate the Reliability of Pattern Identification Tool for Knee Osteoarthritis and to Analyze Correlation between Pattern Identification Tool and Knee Range of Motion, Visual Analog Scale and Western Ontario & Mcmaster Universities Osteoarthritis Index. J Korean Med Rehabil 2019;29(3):113-28.   DOI
12 Lee HS, Kang WC, Jung IC. Reliability and validity analysis of the instrument on pattern identifications for depression. J Orient neuropsychiatry 2015;26(4):407-16.   DOI
13 Homma Y, Kawabe K, Tsukamoto T, Yamanaka H, Okada K, Okajima E, et al. Epidemiologic survey of lower urinary tract symptoms in Asia and Australia using the international prostate symptom score. Int J Urol 1997;4(1):40-6.   DOI
14 Fleiss JL. Statistical Methods for Rates and Proportions. 3rd ed. New York: John wiley & sons; 2003.
15 Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med 2016;15(2):155-63.   DOI
16 Knapp TR. Coefficient alpha: conceptualizations and anomalies. Res Nurs Health 1991;14(6):457-60.   DOI
17 Dancey CP, Reidy J. Statistics without Maths for Psychology. 5th ed. New Jersey: Prentice Hall; 2011, p. 175.
18 Kuo HC. Clinical prostate score for diagnosis of bladder outlet obstruction by prostate measurements and uroflowmetry. Urology 1999;54(1):90-6.   DOI
19 El Din KE, Kiemeney L, De Wildt M, Debruyne FMJ, de La Rosette J. Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score. Urology 1996;48(3):393-7.   DOI
20 Nam SU, Park JW, Kim JS. Correlation Analysis Between Stomach Qi Deficiency Pattern and Gastric Emptying Measured by Abdominal Ultrasonography in Patients with Functional Dyspepsia. J Intern Korean Med 2018;39(3):405-25.   DOI
21 Eum HS, Kim SA, Jung WS, Shin GC, Kang YH. Clinical Report on a Patient with Benign Prostatic Hyperplasia diagnosed as the Deficiency of Yang of the Kidney. J Korea Inst Orient Med informatics 2004;10(2):8-16.
22 Chughtai B, Forde JC, Thomas DDM, Laor L, Hossack T, Woo HH, et al. Benign prostatic hyperplasia. Nat Rev Dis Prim 2016;2(1):1-15.
23 Lee HS, Choi WC, Yu YS, Kang WC, Jung IC. Reliability and validity analysis of the Instrument of Oriental Medical Evaluation for Hwa-Byung. J Orient Neuropsychiatry 2014;25(4):351-8.   DOI
24 Jeong HY, Lee JY, Park YC, Jung IC, Cho CS. Development of a Basic Standard Tool for Pattern Identification of Benign Prostatic Hyperplasia (BPH). J Intern Korean Med 2017;38(3):301-18.   DOI
25 Kim HJ, Moon JH, Oh YH, Kong MH, Park KK, Huh JS. Relationship Between Prostate Volume and Lower Urinary Tract Symptom in Health Checkup Subjects. Korean J Urol Oncol 2020;18(1):53-60.   DOI
26 AUA Practice Guidelines Committee. AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations. J Urol 2003;170(2):530-47.   DOI
27 Bae IS, Jung SH. Effects of the Korean Medicinal Herbs for Treatment of Benign Prostatic Hyperplasia Induced in Rat Models: A Review. J Intern Korean Med 2018;39(4):592-604.   DOI
28 McVary KT, Roehrborn CG, Avins AL, Barry MJ, Bruskewitz RC, Donnell RF, et al. Update on AUA guideline on the management of benign prostatic hyperplasia. J Urol 2011;185(5):1793-803.   DOI
29 Dvorkin L, Song KY. Herbs for benign prostatic hyperplasia. Ann Pharmacother 2002;36(9):1443-52.   DOI
30 Vuichoud C, Loughlin KR. Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 2015;22(Suppl 1):1-6.
31 Madersbacher S, Sampson N, Culig Z. Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review. Gerontology 2019;65(5):458-64.   DOI